Ocuphire Pharma (OCUP) Short Interest Ratio & Short Volume → Chances are you know the firms on this list (From WealthPress) (Ad) Free OCUP Stock Alerts $1.51 -0.15 (-9.04%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Ocuphire Pharma Short Interest DataCurrent Short Volume1,570,000 sharesPrevious Short Volume1,650,000 sharesChange Vs. Previous Month-4.85%Dollar Volume Sold Short$3.16 millionShort Interest Ratio / Days to Cover7.1Last Record DateMarch 31, 2024Outstanding Shares24,810,000 sharesPercentage of Shares Shorted6.33%Today's Trading Volume379,168 sharesAverage Trading Volume221,980 sharesToday's Volume Vs. Average171% Short Selling Ocuphire Pharma ? Sign up to receive the latest short interest report for Ocuphire Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOCUP Short Interest Over TimeOCUP Days to Cover Over TimeOCUP Percentage of Float Shorted Over Time Ad Wealthpin ProOne trade. One ticker. One week. Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. Ocuphire Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20241,570,000 shares $3.16 million -4.9%N/A7.1 $2.01 3/15/20241,650,000 shares $3.14 million -2.4%N/A7.8 $1.90 2/29/20241,690,000 shares $4.29 million -3.4%N/A7.9 $2.54 2/15/20241,750,000 shares $4.64 million +1.2%N/A8.1 $2.65 1/31/20241,730,000 shares $4.53 million +4.2%N/A7.6 $2.62 1/15/20241,660,000 shares $4.98 million +5.1%N/A7.6 $3.00 Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,580,000 shares $4.76 million -9.7%N/A7.3 $3.01 12/15/20231,750,000 shares $4.60 million -0.6%N/A6.2 $2.63 11/30/20231,760,000 shares $5.37 million +3.5%N/A6.4 $3.05 11/15/20231,700,000 shares $5.36 million -2.3%N/A6.5 $3.15 10/31/20231,740,000 shares $4.96 million -7.5%N/A7.1 $2.85 10/15/20231,880,000 shares $6.28 million +3.9%N/A8.2 $3.34 9/30/20231,810,000 shares $6.06 million +27.5%N/A8.1 $3.35 9/15/20231,420,000 shares $5.69 million -2.7%N/A8.2 $4.01 8/31/20231,460,000 shares $5.83 million -8.2%N/A10.2 $3.99 8/15/20231,590,000 shares $6.66 million -1.2%N/A9.5 $4.19 7/31/20231,610,000 shares $6.97 million -1.2%N/A6.8 $4.33 7/15/20231,630,000 shares $6.75 million +5.2%N/A5.1 $4.14 6/30/20231,550,000 shares $6.73 million +5.4%N/A4.2 $4.34 6/15/20231,470,000 shares $5.87 million -4.6%N/A3.8 $3.99 5/31/20231,540,000 shares $5.94 million -24.5%N/A4.1 $3.86 5/15/20232,040,000 shares $10.24 million +11.5%N/A6 $5.02 4/30/20231,830,000 shares $9.39 million +45.2%N/A6.9 $5.13 4/15/20231,260,000 shares $6.75 million +86.7%N/A5.2 $5.36 3/31/2023675,000 shares $2.53 million -25.5%N/A4.2 $3.75 3/15/2023906,400 shares $3.40 million +0.2%N/A7.2 $3.75 2/28/2023904,800 shares $3.12 million -3.4%N/A7 $3.45 2/15/2023936,500 shares $3.59 million -5.8%N/A6.8 $3.83 1/31/2023994,000 shares $3.45 million -7.1%N/A3.7 $3.47 1/15/20231,070,000 shares $3.94 million +5.9%N/A4.4 $3.68 12/30/20221,010,000 shares $3.57 million -3.8%N/A4.3 $3.53 12/15/20221,050,000 shares $3.10 million -1.9%N/A5 $2.95 11/30/20221,070,000 shares $3.30 million -5.3%N/A5.2 $3.08 11/15/20221,130,000 shares $3.22 million +220.3%N/A5.7 $2.85 10/31/2022352,800 shares $829,080.00 +16.5%N/A2 $2.35 10/15/2022302,800 shares $663,132.00 -25.1%N/A3.9 $2.19 9/30/2022404,300 shares $812,643.00 -12.0%N/A5.3 $2.01 9/15/2022459,400 shares $1.06 million -0.4%N/A5.4 $2.30 8/31/2022461,400 shares $1.05 million -16.9%N/A5.1 $2.27 8/15/2022555,500 shares $1.40 million +104.9%N/A5.6 $2.52One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. OCUP Short Interest - Frequently Asked Questions What is Ocuphire Pharma's current short interest? Short interest is the volume of Ocuphire Pharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 1,570,000 shares of OCUP short. Learn More on Ocuphire Pharma's current short interest. What is a good short interest ratio for Ocuphire Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCUP shares currently have a short interest ratio of 7.0. Learn More on Ocuphire Pharma's short interest ratio. Which institutional investors are shorting Ocuphire Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocuphire Pharma: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Ocuphire Pharma's short interest increasing or decreasing? Ocuphire Pharma saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 1,570,000 shares, a decrease of 4.8% from the previous total of 1,650,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Ocuphire Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Ocuphire Pharma: Rockwell Medical, Inc. (2.54%), Bolt Biotherapeutics, Inc. (8.20%), Aadi Bioscience, Inc. (5.41%), Xilio Therapeutics, Inc. (0.67%), NRx Pharmaceuticals, Inc. (6.65%), NextCure, Inc. (4.71%), Clene Inc. (0.13%), CalciMedica, Inc. (0.79%), Eledon Pharmaceuticals, Inc. (0.43%), Marker Therapeutics, Inc. (1.68%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Ocuphire Pharma stock? Short selling OCUP is an investing strategy that aims to generate trading profit from Ocuphire Pharma as its price is falling. OCUP shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ocuphire Pharma? A short squeeze for Ocuphire Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCUP, which in turn drives the price of the stock up even further. How often is Ocuphire Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCUP, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: RMTI Short Squeeze BOLT Short Squeeze AADI Short Squeeze XLO Short Squeeze NRXP Short Squeeze NXTC Short Squeeze CLNN Short Squeeze CALC Short Squeeze ELDN Short Squeeze MRKR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OCUP) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press